<bill session="117" type="s" number="5167" updated="2023-09-05T15:45:28Z">
  <state datetime="2022-12-01">REFERRED</state>
  <status>
    <introduced datetime="2022-12-01"/>
  </status>
  <introduced datetime="2022-12-01"/>
  <titles>
    <title type="display">TEST Act of 2022</title>
    <title type="short" as="introduced">Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2022</title>
    <title type="short" as="introduced">TEST Act of 2022</title>
    <title type="official" as="introduced">A bill to extend the temporary order for fentanyl-related substances.</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-12-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-12-01" state="REFERRED">
      <text>Referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
  </subjects>
  <amendments/>
  <summary date="2023-09-05T15:44:56Z" status="Introduced in Senate">Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2022 or the TEST Act of 2022

This bill (1) extends the temporary scheduling of fentanyl-related substances in schedule I of the Controlled Substances Act for two years; (2) requires the Drug Enforcement Administration to submit synthetic compounds of fentanyl-related substances it has encountered thus far to the Food and Drug Administration for scientific and medical evaluations, if they have not yet been evaluated; and (3) provides for the removal and rescheduling of fentanyl-related substances from schedule I if certain criteria are met, as well as notifications about any such scheduling changes to individuals who were or are being prosecuted for offenses related to such substances.</summary>
</bill>
